Wolverine Trading
SGYP

Wolverine Trading’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Wolverine Trading’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-123,100
Closed -$209K – 5833
2018
Q3 		$209K Buy
123,100
+7,000
+6% +$12.5K ﹤0.01% 4218
2018
Q2 		$212K Hold
116,100
– – ﹤0.01% 4303
2018
Q1 		$212K Sell
116,100
-3,900
-3% -$8.24K ﹤0.01% 4303
2017
Q4 		$268K Buy
120,000
+7,700
+7% +$19.1K ﹤0.01% 3781
2017
Q3 		$326K Buy
112,300
+24,600
+28% +$83.9K ﹤0.01% 3149
2017
Q2 		$382K Buy
+87,700
New +$362K ﹤0.01% 2710
2017
Q1 		– Sell
-88,300
Closed -$538K – 5379
2016
Q4 		$538K Sell
88,300
-54,500
-38% -$285K ﹤0.01% 2539
2016
Q3 		$758K Buy
142,800
+75,700
+113% +$354K ﹤0.01% 2167
2016
Q2 		$251K Buy
+67,100
New +$227K ﹤0.01% 3015

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OCM
Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wolverine Trading's SGYP Position: Q4 2018 in Review

Wolverine Trading sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 54,360 shares — an estimated $92K sold.

Wolverine Trading first reported a position in SGYP in Q2 2016 and held it in 8 quarters. The position peaked at $327K in Q2 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • Wolverine Trading reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • Wolverine Trading sold 54,360 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $92K.
  • Wolverine Trading first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 8 quarters.
  • Wolverine Trading's Synergy Pharmaceuticals, Inc Common Stock position peaked at $327K in Q2 2016.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Wolverine Trading's 13F filing for Q4 2018, filed 14 Feb 2019.